Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 18 Sept 2026 for CRESCENT BIOPHARMA, INC., €10k.
Filing timeline
BuySaleJan Pinkas
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Jan Pinkas: trading record in brief
Jan Pinkas is a declared insider of Crescent Biopharma, Inc., with filings sourced from SEC (Form 4). The record holds 4 filings, for trades running from 15 December 2025 to 16 September 2026.
Sales make up the whole of the open-market record (2 sales, €30k). Outside the open market, there are 2 share grants. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 18 September 2026 with an open-market sale (€10k) in Crescent Biopharma, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jan Pinkas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
658 shares@ US$17.90Ordinary SharesSEC:0001628280-26-062707:0
1,288 sharesOrdinary SharesSEC:0001628280-26-044892:0
17,507 sharesOrdinary SharesSEC:0001628280-25-057687:0
3 of 3 declarations
